Phenotypic Selectivity of Artificial Intelligence–Enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction
Circulation · 04.11.2025 · 152 (18) · 1282-1294
DOI: 10.1161/circulationaha.125.076279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 04.11.2025. Verfasst von Philip M Croon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine (P.M.C., L.S.D., D.B., E.K.O., R.K.). Hauptthemen laut MEDLINE: Electrocardiography, Artificial Intelligence, Cardiovascular Diseases. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS, NHI.
Abstract (Originalsprache)
BACKGROUND: Artificial intelligence (AI)–enhanced ECG (AI-ECG) models are often designed to detect specific anatomical and functional cardiac abnormalities. Understanding the selectivity of their phenotypic associations is essential to inform their clinical use. Here, we sought to assess whether AI-ECG models function as condition-specific classifiers or broader cardiovascular risk markers. METHODS: We included 4 distinct study populations drawn from both electronic health records and prospective cohort studies. We deployed 6 image-based AI-ECG models: 5 validated models for the detection of left ventricular systolic dysfunction, aortic stenosis, mitral regurgitation, left ventricular hypertrophy, and a composite model for structural heart disease; and 1 negative control AI-ECG model for biological sex. Additionally, we developed 6 experimental models designed to identify noncardiovascular conditions. Diagnosis codes from electronic health records and cohorts were transformed into interpretable phenotypes using a phenome-wide association study framework. We assessed associations of AI-ECG probabilities with cross-sectional phenotypes using logistic regression and with new-onset cardiovascular diseases using Cox regression. Pearson correlation coefficients were calculated to compare phenotypic signatures. RESULTS: The study included one random ECG from 233 689 individuals (mean age 59±18 years, 130 084 [56%] women) across sites. Each of the 5 AI-ECG models for structural and functional cardiac disorders was more likely to be associated with cardiovascular phenotypes compared with other phenotype groups (odds ratios ranging from 2.16 to 4.41, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine (P.M.C., L.S.D., D.B., E.K.O., R.K.).
- Cardiovascular Data Science Lab (P.M.C., L.S.D., D.B., E.K.O., R.K.).
- Yale School of Medicine, New Haven, CT (P.M.C., L.S.D., D.B., E.K.O., R.K.).
- Department of Cardiology, University of Amsterdam, Amsterdam, the Netherlands (P.M.C.).
- Section of Biomedical Informatics and Data Science (R.K.).
- Department of Biostatistics, Yale School of Public Health, New Haven, CT (R.K.).
ORCID-Profile: Philip M Croon, Lovedeep S Dhingra, Dhruva Biswas, Evangelos K Oikonomou, Rohan Khera
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
- NHI
Zitieren
APA
Croon, P. M., Dhingra, L. S., Biswas, D., Oikonomou, E. K., & Khera, R. (2025). Phenotypic Selectivity of Artificial Intelligence–Enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction. Circulation, 152(18), 1282-1294. https://doi.org/10.1161/circulationaha.125.076279
Vancouver
Croon PM, Dhingra LS, Biswas D, Oikonomou EK, Khera R. Phenotypic Selectivity of Artificial Intelligence–Enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction. Circulation. 2025;152(18):1282-1294. doi:10.1161/circulationaha.125.076279
BibTeX
@article{Croon2025,
author = {Croon, Philip M and Dhingra, Lovedeep S and Biswas, Dhruva and Oikonomou, Evangelos K and Khera, Rohan},
title = {Phenotypic Selectivity of Artificial Intelligence–Enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction},
journal = {Circulation},
year = {2025},
volume = {152},
number = {18},
pages = {1282--1294},
doi = {10.1161/circulationaha.125.076279}
}
EUVIMED